1 results match your criteria: "Massachusetts General Hospital and Harvard Medical SchoolBostonMA[Affiliation]"

Metachronous pancreatic cancer originating from disseminated founder pancreatic intraductal neoplasias (PanINs).

J Pathol Clin Res

April 2015

Laboratory of Clinical BioinformaticsCenter for Clinical and Biomedical Research, Sapporo Higashi Tokushukai HospitalSapporoJapan; Center for Cancer Research, Massachusetts General Hospital and Harvard Medical SchoolBostonMA, USA.

Clonal populations originated from benign-looking 'founder cells' may spread widely within pancreas instead of being localized in situ before frank pancreatic ductal adenocarcinoma (PDA) can be detected. Metachronous PDA is not common event, and we here sought to define potent origin of multiple PDAs developed in a woman using advanced genetics technologies. Curative resection of pancreatic head tumour was performed; however, 'recurrent' lesions in the remnant pancreas were found 3.

View Article and Find Full Text PDF